Managing patients with side effects and adverse events to immunoglobulin therapy

Gholamreza Azizi,Hassan Abolhassani,Mohammad hossein Asgardoon,Shiva Shaghaghi,Babak Negahdari,Javad Mohammadi,Nima Rezaei,Asghar Aghamohammadi
DOI: https://doi.org/10.1586/17512433.2016.1105131
2015-10-23
Expert Review of Clinical Pharmacology
Abstract:Immunoglobulin therapy has not only served as a lifesaving approach for the prevention and treatment of infections in primary and secondary immunodeficiency diseases, but has also been used as an immunomodulatory agent for autoimmune and inflammatory disorders and to provide passive immunity for some infectious diseases. Most of the adverse effects associated with immunoglobulin therapy are mild, transient and self-limiting. However, serious side effects also occur. Therefore, to minimize the adverse events of immunoglobulin therapy, specialist review of patient clinical status and immunoglobulin products, in addition to selection of appropriate treatment strategy for the management of patients with associated side effects and adverse events, are crucial.
pharmacology & pharmacy
What problem does this paper attempt to address?